Evidence map›Paper›PMID 32010327›Full record

ArticleExperimental and therapeutic medicine2020

Short-term impact of aged garlic extract on endothelial function in diabetes: A randomized, double-blind, placebo-controlled trial.

Sajad Hamal, Lavanya Cherukuri, Divya Birudaraju, Suguru Matsumoto, April Kinninger, Bhanu T Chaganti, Ferdinand Flores, Kashif Shaikh, Sion K Roy, Matthew J Budoff

2 registry-linked trialsOpen access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT05803759 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on the Effectiveness of Treatment of Patients After Coronary Arteria Revascularization

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2025Enrolled200ConditionsMyocardial Ischemia, Coronary Artery Bypass Grafting, Coronary Arteriosclerosis, Percutaneous Coronary RevascularizationArmsAllicor, Placebo
NCT05813171 phase4unknown statusnot on this mapstarted 2023, after this paper: background citation

The Effects of Dietary Supplementation Allicor on Patients With Multifocal Atherosclerosis After Peripheral Artery Revascularization Treatment During a Year

TypeinterventionalSponsorInstitute for Atherosclerosis Research, RussiaRan2023 to 2024Enrolled300ConditionsAtherosclerosis, Peripheral Arterial DiseaseArmsAllicor, Placebo
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Efficacy of Watercress (Antioxidants (Basel, Switzerland) · 2026
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Anticoagulant Effect of Snow mountain garlic:Molecules (Basel, Switzerland) · 2024
    Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Sajad HamalLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Lavanya CherukuriLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Divya BirudarajuLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Suguru MatsumotoLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
April KinningerLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Bhanu T ChagantiLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Ferdinand FloresLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Kashif ShaikhLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Sion K RoyLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
Matthew J BudoffLundquist Institute for Biomedical Innovation at Harbor UCLA Medical Center, Torrance, CA 90502, USA.
UCLA Medical Center · USHarbor–UCLA Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Impaired endothelial function portends an increased risk of cardiovascular disease. Vascular oxidative stress and systemic inflammation play a critical role in the pathogenesis and progression of vascular disease. Aged garlic extract (AGE) may improve impaired vascular endothelial function, while decreasing the progression of atherosclerotic plaque. We hypothesized that AGE may improve endothelial function, and in this study, we examined this hypothesis to determine whether this can be achieved over a period of 3 months, measured by the cardio-ankle vascular index (CAVI), by reducing intracellular oxidant stress and stimulating nitric oxide generation in endothelial cells. We conducted a double-blinded placebo controlled, randomized clinical trial to investigate the effects of AGE on CAVI in subjects with type 2 diabetes mellitus. A total of 65 individuals (38 men and 27 women) with a mean age of 58.8±11.1 years were enrolled and randomized to the AGE or placebo group in a double-blind placebo controlled trial. An ANOVA model with treatment as the main effect was used to compare changes in CAVI from baseline to follow-up between groups. The primary objective of this study was reduction in CAVI over a 3-month period. In the AGE group, CAVI was reduced on average by 0.71±1.27 vs. a mean reduction of 0.13±0.94 in the placebo group (P=0.04). On the whole, this study demonstrates that AGE has a positive impact on endothelial function in patients with T2DM and may play a role in the primary prevention of cardiovascular disease.

Indexed as

diabetesendothelial functiongarlicrandomized trial

Identifiers

PMID32010327
PMCPMC6966134
OpenAlexW2998294770

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.